Home > National Drug Code (NDC) > Western Black Willow

Western Black Willow - 49288-0606-3 - (Western Black Willow)

Alphabetical Index


Drug Information of Western Black Willow

Product NDC: 49288-0606
Proprietary Name: Western Black Willow
Non Proprietary Name: Western Black Willow
Active Ingredient(s): .05    g/mL & nbsp;   Western Black Willow
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Western Black Willow

Product NDC: 49288-0606
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19740323

Package Information of Western Black Willow

Package NDC: 49288-0606-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0606-3)

NDC Information of Western Black Willow

NDC Code 49288-0606-3
Proprietary Name Western Black Willow
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0606-3)
Product NDC 49288-0606
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Western Black Willow
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19740323
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name SALIX LUCIDA SSP. LASIANDRA POLLEN
Strength Number .05
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Western Black Willow


General Information